Presentation TCT 8: Impact of Aspirin Resistance on Outcomes After Coronary Events Presenter: Christine Chung October 31, 2016 REGISTER for free or LOG IN to view this content Coronary Presentation TCT 2016 CAD Pharma Up Next Presentation TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR Presenter: Elmir Omerovic October 31, 2016 More slides + Presentation The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors Presenter: Gregg W. Stone October 31, 2016 Presentation Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Daniel Burkhoff October 31, 2016 We Recommend
Presentation TCT 3: Pretreatment With P2Y12 Receptor Antagonists Is Not Associated With Improved Patency of Infarct Related-Artery in STEMI A Report from SCAAR Presenter: Elmir Omerovic October 31, 2016
Presentation The FDA Town Hall Meeting: Evolution of a Decades Long Collaboration Between Physician-Scientists, Industry, Regulators, and Payors Presenter: Gregg W. Stone October 31, 2016
Presentation Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me! Presenter: Daniel Burkhoff October 31, 2016